Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: Are self-reported menstrual disorders associated with hyperandrogenaemia and metabolic disturbances as early as in adolescence? SUMMARY ANSWER: Menstrual disorders at the age 16 are a good marker of hyperandrogenaemia, and an adverse lipid profile was associated with higher androgen levels. WHAT IS KNOWN AND WHAT THIS PAPER ADDS: Hyperandrogenism per se has been suggested to be a significant metabolic risk factor in women and a cause of physical and psychological morbidity in adolescent girls. A weak positive correlation has been described between hyperandrogenaemia and obesity in adolescent girls, but the clinical consequences are still poorly understood. Hyperandrogenism and insulin resistance are also key features of polycystic ovary syndrome (PCOS), and women with PCOS are consequently at an increased risk of developing type 2 diabetes mellitus and/or metabolic syndrome, and may have increased cardiovascular morbidity. Our findings confirm that the association between menstrual disorders, hyperandrogenism, obesity and metabolic risks is already evident in adolescence. STUDY DESIGN: This population-based, cross-sectional study used postal questionnaires to targeting 15-16-year-old girls in the Northern Finland Birth Cohort 1986 (n= 4567). PARTICIPANTS AND SETTING: There were 3669 girls who answered the postal questionnaire and out of 3373 girls who also underwent clinical examinations and blood tests, 2448 were included in the analyses. The questionnaire included one question about the regularity and length of the menstrual cycle: 'Is your menstrual cycle (the interval from the beginning of one menstrual period to the beginning of the next period) often (more than twice a year) longer than 35 days?' The girls who answered 'yes' to this question were considered to be suffering from menstrual disorders and were classified as 'symptomatic'. The girls who answered 'no' were defined as 'non-symptomatic'. MAIN RESULTS AND THE ROLE OF CHANCE: There were 709 (29%) girls who reported menstrual disorders (symptomatic girls) and 1739 who had regular periods (non-symptomatic girls). In the whole population and in both study groups, there were significant correlations between body mass index (BMI) (and waist-to-hip ratio), hyperandrogenaemia and metabolic parameters. Symptomatic girls exhibited significantly higher serum concentrations of testosterone (P= 0.010), lower levels of sex hormone-binding globulin (P =0.042) and higher free androgen indices [FAIs; geometric mean 3.38 (interquartile range (IQR): 2.27, 5.18) versus 3.08 (IQR: 2.15, 4.74), P= 0.002]. The two groups had comparable BMI and insulin sensitivity, and serum levels of glucose, insulin and lipids. There was a significant linear trend towards higher FAI values in the higher BMI quartiles in both symptomatic and non-symptomatic girls. In the whole population, there was a statistically significant linear decrease in high-density lipoprotein concentrations (P < 0.001) and higher triglyceride concentrations (P =0.004) in the upper FAI quartile. IMPLICATIONS: Information regarding menstrual disorders in adolescence is a good marker of hyperandrogenaemia and may be an early risk factor for the development of PCOS in adulthood. The association between obesity, hyperandrogenism and metabolic risks is already evident in adolescence, which strengthens the importance of noting menstrual disorders at an early stage. BIAS, LIMITATIONS, GENERALIZABILITY: The cross-sectional nature of the study does not allow us to draw conclusions concerning the metabolic risks of this population in later life. The diagnosis of menstrual disorders was based on a questionnaire, suggesting a risk of information bias in reporting the symptoms. This study was not designed to diagnose PCOS, as ultrasonography was not available and there was no clinical evaluation of hyperandrogenism (i.e. hirsutism). However, we were able to take into account potential confounding factors in the analyses. STUDY FUNDING/COMPETING INTERESTS: This work was supported by grants from the Finnish Medical Society Duodecim, the North Ostrobothnia Regional Fund, the Academy of Finland (project grants 104781, 120315, 129269, 1114194, SALVE), University Hospital Oulu, Biocenter, University of Oulu, Finland (75617), the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643) and the Medical Research Council, UK (PrevMetSyn/SALVE). None of the authors have any conflict of interest to declare.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Self-citationWild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Menstrual cycle irregularity and risk for future cardiovascular disease
Solomon, C. G., Hu, F. B., Dunaif, A., Rich-Edwards, J. E., Stampfer, M. J., Willett, W. C., Speizer, F. E., & Manson, J. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8471 · Cited by 528
Ibañez, L., Potau, N., Virdis, R., Zampolli, M., Terzi, C., Gussinyé, M., Carrascosa, A., & Vicens-Calvet, E. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.8501168 · Cited by 341 · cited 1×
“In other studies, however, preadolescent girls who later developed PCOS had significantly earlier pubarche and thelarche (Ibanez et al., 1993; Ibanez et al., 2008), but large studies addressing the age at menarche in relation to PCOS are lacking.”
BackgroundEarly Menarche, a Risk Factor for Breast Cancer, Indicates Early Onset of Ovulatory Cycles*
APTER, D., & VIHKO, R. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-1-82 · Cited by 323
Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome
Lewy, V. D., Danadian, K., Witchel, S. F., & Arslanian, S. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.109603 · Cited by 298 · cited 3×
“Adolescent hyperandrogenaemia is associated with hirsutism, acne and menstrual irregularity and it is an important marker of PCOS and subsequent risk of T2DM, especially when associated with obesity (Lewy et al., 2001).”
BackgroundInfluentialJääskeläinen, J., Levo, A., Voutilainen, R., & Partanen, J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4271 · Cited by 149 · cited 1×
“Lastly, the girls were not screened for late onset adrenal hyperplasia, but the prevalence of this disorder in our country is considerably lower than that reported for other populations (under 1/15 000; Jaaskelainen et al., 1997).”
ResultFruzzetti, F., Perini, D., Lazzarini, V., Parrini, D., & Genazzani, A. R. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.004 · Cited by 95
Prospective follow‐up of menstrual disorders in adolescence and prognostic factors
WIKSTEN‐ALMSTRÖMER, M., HIRSCHBERG, A. L., & HAGENFELDT, K. (2008) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1080/00016340802478166 · Cited by 80 · cited 1×
“…prospective study of menstrual disturbances in adolescents demonstrated that after 6 years of follow-up, irregular menstruation was still present in 62%, and that 59% of those with persisting irregular menstruation fulfilled the criteria for diagnosis of PCOS (Wiksten-Almstromer et al., 2008).”
Background
Cited by
Day, F., Karaderi, T., Jones, M. R., Meun, C., He, C., Drong, A., Kraft, P., Lin, N., Huang, H., Broer, L., et al. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007813 · Cited by 619
“For the analysis of PCOS related traits three additional cohorts, the Northern Finnish Birth Cohort (NFB66) [40], Twins UK [41] and the Nurses’ Health Study (NHS) [42] were included.”
Self-citationOllila, M.-M. E., Piltonen, T., Puukka, K., Ruokonen, A., Järvelin, M.-R., Tapanainen, J. S., Franks, S., & Morin-Papunen, L. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3543 · Cited by 182
“In line with this, previous studies have suggested that PCOS manifested itself after a significant weight gain (7) and that obesity was strongly associated with hyperandrogenemia already in adolescence (33, 34), with a higher risk of PCOS and infertility problems in later life (35).”
ResultSelf-citationWest, S., Lashen, H., Bloigu, A., Franks, S., Puukka, K., Ruokonen, A., Jarvelin, M. R., Tapanainen, J. S., & Morin-Papunen, L. (2014) · Human Reproduction · doi:10.1093/humrep/deu200 · Cited by 94
Self-citationPeña, A. S., Doherty, D. A., Atkinson, H. C., Hickey, M., Norman, R. J., & Hart, R. (2018) · Archives of Disease in Childhood · doi:10.1136/archdischild-2017-312968 · Cited by 47
Pinola, P., Morin-Papunen, L. C., Bloigu, A., Puukka, K., Ruokonen, A., Jarvelin, M. R., Franks, S., Tapanainen, J. S., & Lashen, H. (2014) · Human Reproduction · doi:10.1093/humrep/deu182 · Cited by 41
Self-citation
Metadata
- Authors
- Pinola, P., Lashen, H., Bloigu, A., Puukka, K., Ulmanen, M., Ruokonen, A., Martikainen, H., Pouta, A., Franks, S., Hartikainen, A. L., Jarvelin, M. R., & Morin-Papunen, L.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-08-29
- Volume
- 27
- Issue
- 11
- Pages
- 3279-3286
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2124707313
- Cited by
- 60
- References
- 9
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study. https://app.cochat.ai/papers/10.1093/humrep/des309
- The paper
- Pinola, P., Lashen, H., Bloigu, A., Puukka, K., Ulmanen, M., Ruokonen, A., Martikainen, H., Pouta, A., Franks, S., Hartikainen, A. L., Jarvelin, M. R., & Morin-Papunen, L. (2012). Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study. Human Reproduction. https://doi.org/10.1093/humrep/des309
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.